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Abstract
Background: Streptococcus Suis (S.suis) is increasingly being recognised as a potentially preventable emerging zoonotic
infection in humans with a global distribution. It is a major cause of meningitis especially among those in contact with
pigs and has also been associated with a toxic shock syndrome.
Case presentations: We report the first two human cases from Sabah, Borneo, Malaysia which expands the global
reach of this important pathogen. Here, we illustrate their epidemiological risk factors, clinical presentation and
resulting sequelae of both patients.
Conclusion: The continued public health threat of zoonotic infections such as S.suis, highlights the need for accurate
epidemiological surveillance, regulation of pig farming, slaughtering and continued advocacy of best practices for pork
preparation and consumption.
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Background
Streptococcus suis (S.suis) is a porcine zoonotic infection
which is increasingly recognised. Meningitis and septi-
caemia have been described as the most common clin-
ical syndromes [1]. Since the first reported human case
in Denmark, increasing numbers have been reported
worldwide [2]. In South East Asia, Thailand and
Vietnam have reported the largest number of cases with
sporadic reports from Singapore, Philippines and Laos
[2]. To date, there have not been any cases reported
from Malaysia or Indonesia partly because of the limited
pig rearing due to cultural reasons. We report two cases
from Sabah, Borneo, Malaysia.
Case report
The first patient was a 41-year-old previously healthy man
who presented with 2 day history of fever, headache,
vomiting, neck pain and behavioural change. He reared
four pigs at home and had daily contact with them. On
examination, he was confused and disorientated, with a
Glasgow Coma Scale (GCS) 7/15, hypotensive with a
blood pressure of 89/57 mmHg, and had meningeal signs,
however there was no rash noted. He was intubated for
airway protection, started on noradrenaline, ceftriaxone
and acyclovir. Blood tests indicated leucocytosis (13.7 ×
109 white blood cell/L), neutrophilia (12.63 × 109 neutro-
phils/L), lymphopenia (0.72 × 109 lymphocytes/L), elevated
C-reactive protein (320 mg/L), and hypoalbuminemia
(28 g/L). Contrast enhanced computed tomography of the
brain and transthoracic echocardiogram were normal.
Lumbar puncture done 12 h after admission and initial
antibiotic administration showed an opening pressure of
27 cmH20 and the cerebrospinal fluid (CSF) was noted to
be cloudy with a protein level of 2.16 g/L, a glucose level
of 1.98 mmol/L (concomitant serum glucose was
7.6 mmol/L), and 95 leukocytes/μL (30% neutrophils and
65% lymphocytes). CSF gram stain and culture did not
reveal any organism however blood cultures after 3 h of
incubation were positive for gram positive cocci in chains.
Culture specimens were plated on blood agar and after
18 h of incubation in 37 °C under aerobic conditions, the
growth showed alpha haemolytic colonies which were
catalase negative. These colonies were identified using
matrix-assisted laser desorption ionization time-of-flight
* Correspondence: gsrajahram@gmail.com
1Infectious Diseases Unit, Department of Medicine, Queen Elizabeth Hospital,
Kota Kinabalu, Sabah, Malaysia
2Clinical Research Centre, Queen Elizabeth Hospital, Kota Kinabalu, Sabah,
Malaysia
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Rajahram et al. BMC Infectious Diseases  (2017) 17:188 
DOI 10.1186/s12879-017-2294-z
mass spectrometry (MALDI-TOF MS) VITEK® MS
MALDI-TOF MS (bioMériux) as Streptococcus suis with a
99.9% probability score. Antibiotic susceptibility testing
was carried out according to the Clinical Science La-
boratory Institute [3] testing recommendation using the
Kirby-Bauer method. The strain was sensitive to peni-
cillin and ceftriaxone the minimal inhibitory concentra-
tion (MIC) of penicillin and ceftriaxone were identified
by epsilometer test (E-test bioMériux) with an MIC
<0.12 ug/ml and <1.0ug/ml respectively). The patient
was extubated after 48 h and continued to make a good
clinical recovery with antibiotics and completed a two
week course of ceftriaxone. However, in the second
week of admission he developed tinnitus with reduced
hearing in both ear associated with vertigo, loss of bal-
ance and nausea. He was scheduled for a pure tone
audiometry on clinic follow up upon discharge however
defaulted his appointment and we do not have any rec-
ord of permanent eighth nerve damage.
The second patient was a 44-year-old man, presented
with a 2 day history of fever with chills and rigors associ-
ated with headache and vomiting. On examination he was
alert and conscious with no signs of meningism. He had
no fever on admission, the blood pressure was 124/
68 mmHg and heart rate 81 beats per minute. Systemic
examination was unremarkable. He worked as a butcher in
local market handling pork and had injured his thumb
while slaughtering a pig two days prior to onset of symp-
toms. Blood tests showed leucocytosis (35.4 × 109 white
blood cell/L), neutrophilia (33.04 × 109 neutrophils/L), lym-
phopenia (0.70 × 109 lymphocytes/L), elevated C-reactive
protein (226.8 mg/L), and hypoalbuminemia (29 g/L).
Blood culture on admission and antibiotic susceptibility
testing performed by methods described above was positive
for Streptococcus suis which was sensitive to penicillin.
Lumbar puncture performed 48 h after admission was nor-
mal with no white blood cells and normal glucose and pro-
tein. His echocardiogram also did not show any evidence
of endocarditis. He completed two weeks of intravenous
penicillin G and made complete recovery on discharge
without any residual neurological or otological deficits.
Discussion
Consistent with previous reports [1, 2, 4] both our pa-
tients had significant exposure to pigs prior to develop-
ing infection. In Asia, besides direct trauma as with our
second patient, it is increasing recognised that subopti-
mal preparation and consumption of pork and its organs
may increase the risk of acquiring this disease [1, 2, 4].
The first patient presented with meningitis associated
with bacteraemia and developed hearing loss and ves-
tibular symptoms during the course of admission. This
is consistent with previous reports of S. suis meningitis
with labyrinthitis [5] and sensory neural hearing loss
occurring in up to 2/3rd of patients with a guarded
prognosis for recovery [4]. The use of dexamethasone
therapy in association to reducing hearing loss is contro-
versial, with one study showing reduction in severe hear-
ing loss [4] and a subsequent case series demonstrating
hearing loss continued to occur despite therapy [6]. As
with other forms of bacterial meningitis, the best out-
comes are likely to be obtained by early recognition and
rapid administration of parenteral antibiotics, combined
administration of dexamethasone patients with a history
of porcine exposure, and in regions with a high prevalence
of S.suis meningitis [7]. Referral to the Otorhinolaryngolo-
gist for audiometry and vestibular testing may be needed
including early evaluation for cochlear implant [8].
Although meningitis is the most common described
presentation of S.suis infection, sepsis, uveitis, endoptahl-
mitis, endocarditis, arthritis and spondylodiscitis have all
been previously reported [1, 2]. Of note, large outbreaks in
China have described streptococcal toxic shock syndrome
(STSS) associated with S. suis infection with rapid clinical
deterioration including purpura fulminans and high mor-
tality [9, 10]. While this syndrome has not been recognised
outside of China, there is a concern that limited diagnostic
resources and a lack of accessibility to healthcare may be
the reason why this is so in other parts of Asia.
To date, 29 serotypes S.suis have been described [11].
The majority of human cases have been attributed to
serotype 2 with also some sporadic cases from other se-
rotypes, mainly serotype 1410. Reliable multiplex PCR
methods are replacing traditional biochemical based
methods in detecting these serotype [12], this coupled
with multilocus sequence typing (MLST) this has led to
better epidemiological characterization and improved
understanding virulence patterns of this organism [11].
Unfortunately, these were not available in our regional
hospital as the need for specialised expertise and funding
limits such testing to regional and national reference
laboratories or in an academic setting.
Conclusion
In summary our cases illustrate the common clinical pres-
entation and sequelae associated with Streptococcus suis
infection. Although it is a common zoonotic infection in
certain parts of Asia, the true burden of illness in Malaysia
in not know. The continued public health threat of zoo-
notic infections such as S.suis, highlights the need for ac-
curate epidemiological surveillance, regulation of pig
farming, slaughtering and continued advocacy of best
practices for pork preparation and consumption.
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